Trupanion (TRUP) Scheduled to Post Quarterly Earnings on Wednesday

Trupanion (NASDAQ:TRUP) will release its earnings data after the market closes on Wednesday, October 30th. Analysts expect Trupanion to post earnings of ($0.06) per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Thursday, August 8th. The financial services provider reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.04. The business had revenue of $314.80 million for the quarter, compared to analyst estimates of $309.33 million. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The company’s quarterly revenue was up 16.3% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.33) EPS. On average, analysts expect Trupanion to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Trupanion Stock Up 1.0 %

Shares of NASDAQ TRUP opened at $53.61 on Monday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63. The stock’s 50-day simple moving average is $46.12 and its two-hundred day simple moving average is $35.24. Trupanion has a twelve month low of $19.14 and a twelve month high of $55.74.

Insider Buying and Selling

In related news, CEO Margaret Tooth sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the transaction, the chief executive officer now directly owns 99,984 shares in the company, valued at $4,647,256.32. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CFO Fawwad Qureshi sold 640 shares of Trupanion stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $43.12, for a total transaction of $27,596.80. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Margaret Tooth sold 7,500 shares of Trupanion stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now directly owns 99,984 shares in the company, valued at approximately $4,647,256.32. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 8,764 shares of company stock worth $405,238 in the last ninety days. 5.50% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

TRUP has been the topic of a number of research analyst reports. Bank of America upped their target price on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. William Blair assumed coverage on Trupanion in a research note on Friday, July 19th. They issued an “outperform” rating on the stock. Northland Securities increased their price objective on Trupanion from $35.00 to $45.00 and gave the company a “market perform” rating in a research report on Thursday, September 19th. Evercore ISI upgraded Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Finally, Stifel Nicolaus increased their price objective on Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research report on Monday, September 23rd. Four equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $41.83.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.